L-arginine normalizes coronary vasomotion in long-term smokers

Circulation

Volumn 99, Issue 4, 1999, Pages 491-497

  Campisi, Roxana ^a   Czernin, Johannes ^a   Schöder, Heiko ^a   Sayre, James W ^a   Scheiben, Heinrich R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood flow; Cold pressor test; Endothelium; Smoking; Tomography

Indexed keywords

AMMONIA; ARGININE; NICOTINE; NITRIC OXIDE; NITROGEN 13;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CIGARETTE SMOKING; CLINICAL ARTICLE; COLD PRESSOR TEST; CONTROLLED STUDY; CORONARY BLOOD VESSEL; CORONARY HEMODYNAMICS; ENDOTHELIUM LESION; FEMALE; HEART MUSCLE BLOOD FLOW; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0033514262     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.4.491     Document Type: Article

References (42)

1. Zeiher AM, Schaechinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 1995;92:1094-l 100.
2. Selwyn AP, Kinlay S, Creager M, Libby P, Ganz P. Cell dysfunction in atherosclerosis and the ischernic manifestations of coronary artery disease. Am J Cardiol. 1997;79;17-23.
3. Campisi R, Czemin J. Schöder H, Sayre JV, Marengo FD, Phelps ME, Scheiben HR. Effects of long-term smoking on myocardial blood flow, coronary vasomotion and vasodilator capacity. Circulation. 1998;98: 119-125.
4. Zeiher A, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol. 1989;14:1181-1190.
5. Nabel EG. Biology of the impaired endothelium. Am J Cardiol. 1991;68: 6C-SC.
6. Zeiher A, Drexler H, Wollschläger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation. 1991 ; 84:1984-1992.
7. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Aled. 1993:329:2002-2012.
8. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991:338:1546-1550.
9. Chauhan A, More RS, Mullins PA, Taylor G, Petch MC, Schofield PM. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Call Cardiol. 1996;28:1796-1804.
10. Benowitz NL. Drug therapy: pharmacologie aspects of cigarette smoking and nicotine addition. N Engl J Med. 1988;319:1318-1330.
11. Czernin J, Müller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, Scheiben HR. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. I993;88:62-69.
12. Adam L-E, Zaers J, Ostertag H, Trojan H, Bellemann ME, Brix G. Performance evaluation of the whole-body PET scanner ECAT EXACT HRfollowing the IEC standard. IEEE Trans Niicl Sei. 1997;44: 1172-1179.
13. Weinberg IN, Huang SC, Huffman EJ, Araujo L, Nienaber C, Grover-McKay M, Dahlbom M, Scheiben H. Validation of PET-acquired functions for cardiac studies. J Nucl Med. 1988;29:241-247.
14. Di Carli MF, Tobes MC, MangnerT, Levine AB, Muzik O, Chakroborty P, Levine TB. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med. 1997;336:1208-1215.
15. Huffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography. J Comput Assist Tomogr. 1979;3:299-30S.
16. Kuhle WG, Porenta G, Huang S-C, Buxton D, Gambhir SS, Hansen H, Phelps ME, Scheiben HR. Quantification of regional myocardial blood flow using '3N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation. I992;86:1004-1017.
17. Kaplan LA, Pesce AJ. Clinical Chemistry: Theory. Analysis and Correlation. 1st ed. St Louis, Mo: Mosby; 1984:1195-1209.
18. Farmer JA, Gotto AM. Risk factors for coronary artery disease. In: Braunwald E, ed. Heart Disease. Philadelphia, Pa: WB Saunders Co; 1992:1125-1160.
19. Benson JR, Hare PE. O-phthalaldehyde: fluorogenic detection of primary amines in the picomole range: comparison with fluorescamine and ninhydrin. Proc Nat! AcadSei USA. I975;72:619-622.
20. Ishida Y, Fujita T, Asai K. New detection and separation methods for amino acids by high-performance liquid chromatography. J Chromatogr. 1981:204:143-148.
21. Marcus M. Methods of calculating coronary vascular resistance. In: Marcus M, ed. The Coronary Circulation in Health and Disease. New York, NY: McGraw-Hill; 1983:107-109.
22. National Cholestérol Education Program. Second report of the Expert Panel on Détection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1333-I445.
23. Gellman J, Hare JM, Lowenstein CJ, Gerstenblith G, Coombs VJ, Brinker JA, Resar JR. Intracoronary L-arginine normalizes the paradoxical response of atherosclerotic coronary arteries to adrenergic stimulation. Circulation. 1996;94(suppl I):I-242. Abstract.
24. Tousoulis D, Davies G, Tentolouris C, Crake T, Toutouzas P. Inhibition of nitric oxide synthesis during the cold presser test in patients with coronary artery disease. Am J Cardiol. 1997:79:1676-1679.
25. Creager MA, Gallagher SI, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992:90:1248-1253.
26. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension. 1993:22:812-818.
27. Pieper GM, Peltier BA. Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J Cariliovasc Pliarmacol. 1995;25:397-403.
28. Adams MR, Jessup W, Celermajer DS. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral 1-arginine but not vitamin C. J Am Coll Cardia]. 1997;29:491-497.
29. Nagamachi S, Czcrnin J, Kirn AS, Sun KT, Böttcher M, Phelps ME, Scheiben HR. Reproducibility of measurements of regional resting and hypcrcmic myocardial blood How assessed with PET. J Nucl MeJ. 1996:37:1626-1631.
30. Harrison DO. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 1997; 100:2153-2157.
31. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae: specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Cliem. 1996;271:22810 -22814. -
32. G-hydroxy-L-arginine during high output NO production. Am J Physiol. I996;272:H1988-H1998.
33. Meijer AJ, Lamers WH, Chamuleau RAFM. Nitrogen metabolism and ornithine cycle function. Physiol Rev. 1990;70:701-748.
34. Albina JE, Caldwell MD, Henry WL, Mills CD. Regulation of macrophage functions by L-arginine. J Exp Med. 1989;I69:I021-1029.
35. Ratner S. Enzymes of arginine and urea synthesis. Adv Enzymol. 1973; 39:1-90.
36. Wu G, Meininger CJ. Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat. Am J Physiol. 1995;269:H1312-H1318.
37. Giugliano D, Marfella R, Verazzo G, Acampora R, Coppola L, Cozzolino D, D'Onofrio F. The vascular effects of L-arginine in humans: the role of endogenous insulin. J Clin Invest. 1997:99:433-438.
38. Arnal J-F, Miinzel T, Venema RC, James NL, Bai CL, Milch WE, Harrison DG. Interactions between L-arginine and L-glutamine change endothelial NO production: an effect independent of NO synthase substrate availability. J Clin Invest. 1995;95:2565-2572.
39. Vallance PA, Leone A, Calver J, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-575.
40. Wascher TC, Posch K, Wallner S, Hermetter A, Kostner CM, Graier WF. Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase? Biocliem Biophys Res Comm. 1997;234:35-38.
41. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Dates JA, Roberts LJ. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J filed. 1995; 332:1198-1203.
42. Philis-Tsimikas A, Witztum JL. L-Arginine may inhibit atherosclerosis through inhibition of LDL oxidation. Circulation. 1995;92(suppl I):I-422. Abstract.